ClinicalTrials.Veeva

Menu

IVM Versus Standard IVF in Infertile Patients Diagnosed With PCOS

J

Jie Qiao

Status

Unknown

Conditions

PCOS

Treatments

Procedure: standard IVF
Drug: In vitro maturation

Study type

Interventional

Funder types

Other

Identifiers

NCT03463772
IVM/IVF-PCOS

Details and patient eligibility

About

A single center, prospective, open-label, non-inferiority randomized controlled clinical trials (1:1 treatment ratio) regarding pregnancy outcomes between IVM and standard IVF among infertility couples with PCOS in China.

Full description

A single center, randomized controlled clinical trial will enroll 350 couples with PCOS undergoing their first cycle of IVF. The participation in this study will be approximately 2 years with a total of 7 visits from the cycle beginning, pregnancy to delivery. On day 2 or day 3 following the onset of menstrual bleeding, eligible patients will be allocated to two groups at a ratio of 1:1- IVM protocol, and standard IVF protocol. All participants will be randomized through stratified block randomization according to the study sites.

Enrollment

350 patients

Sex

Female

Ages

20 to 38 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Infertile couples scheduled for their first IVF cycle.
  2. Women diagonosed with polycystic ovarian syndrome.
  3. Voluntary participation and informed consent obtained.

Exclusion criteria

  1. Couple with contraindication for IVF or ICSI.
  2. Couples receiving donor sperm or donor eggs.
  3. Couples with indications or have plan to receive PGD and PGS.
  4. Sperm analysis diagnosed as azoospermia;
  5. Either male partner or female partner with an abnormal chromosome karyotype (chromosome polymorphisms was not included).
  6. Women who have undergone unilateral ovariectomy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

350 participants in 2 patient groups

standard IVF
Active Comparator group
Description:
On the Day2/3 of the menstrual cycle, qualified participants will be randomized into either of two groups. Participants in group A will receive standard IVF procedure. Other standard assisted reproductive treatments are similar and parallel between two groups.
Treatment:
Procedure: standard IVF
In vitro maturation
Active Comparator group
Description:
On the Day2/3 of the menstrual cycle, qualified participants will be randomized into either of two groups. Participants in group B will receive IVM procedure.Other standard assisted reproductive treatments are similar and parallel between two groups.
Treatment:
Drug: In vitro maturation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems